News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
The commission will develop a framework for scientists, clinicians, and regulatory authorities on the appropriate use of human germline genome editing.
The two-year award will fund development and commercialization of the firm's HLS-Catch platform and follows a previous grant of $191,535.
The researchers used circularly permuted Cas9 variants to produce four cytosine and four adenine base editors with an expanded editing window.
To solve the problem, the researchers developed new variants of the editors that still edit DNA efficiently but have significantly lower RNA editing activity.
As CRISPR technology continues to progress, some researchers are turning their focus to discovering or developing countermeasures and controls.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.
In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.
NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.
This webinar will discuss a study that used CRISPR/Cas9 to engineer mice harboring risk variants associated with glaucoma in order to assess their functional relevance.
This webinar will discuss the impact of affordable de novo genome assemblies on crop research.